ATE299506T1 - Verfahren zur herstellung von pyrazolo(1,5- b)pyridazin-derivaten - Google Patents

Verfahren zur herstellung von pyrazolo(1,5- b)pyridazin-derivaten

Info

Publication number
ATE299506T1
ATE299506T1 AT00990004T AT00990004T ATE299506T1 AT E299506 T1 ATE299506 T1 AT E299506T1 AT 00990004 T AT00990004 T AT 00990004T AT 00990004 T AT00990004 T AT 00990004T AT E299506 T1 ATE299506 T1 AT E299506T1
Authority
AT
Austria
Prior art keywords
6alkyl
6alkoxy
nsc1
fluorine atoms
substituted
Prior art date
Application number
AT00990004T
Other languages
English (en)
Inventor
Neil Mathews
Richard A Ward
Andrew J Whitehead
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE299506T1 publication Critical patent/ATE299506T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/24Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
AT00990004T 1999-12-22 2000-12-20 Verfahren zur herstellung von pyrazolo(1,5- b)pyridazin-derivaten ATE299506T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9930358.8A GB9930358D0 (en) 1999-12-22 1999-12-22 Process for the preparation of chemical compounds
PCT/EP2000/013001 WO2001046194A2 (en) 1999-12-22 2000-12-20 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives

Publications (1)

Publication Number Publication Date
ATE299506T1 true ATE299506T1 (de) 2005-07-15

Family

ID=10866856

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00990004T ATE299506T1 (de) 1999-12-22 2000-12-20 Verfahren zur herstellung von pyrazolo(1,5- b)pyridazin-derivaten

Country Status (22)

Country Link
US (1) US6803463B2 (de)
EP (1) EP1242424B1 (de)
JP (1) JP2003518121A (de)
KR (1) KR20020062362A (de)
CN (1) CN1197864C (de)
AT (1) ATE299506T1 (de)
AU (1) AU776777B2 (de)
BR (1) BR0016549A (de)
CA (1) CA2395569A1 (de)
CZ (1) CZ20022178A3 (de)
DE (1) DE60021286T2 (de)
ES (1) ES2243343T3 (de)
GB (1) GB9930358D0 (de)
HK (1) HK1047586B (de)
HU (1) HUP0203407A3 (de)
IL (1) IL150274A0 (de)
MX (1) MXPA02006132A (de)
NO (1) NO323412B1 (de)
NZ (1) NZ519691A (de)
PL (1) PL356141A1 (de)
WO (1) WO2001046194A2 (de)
ZA (1) ZA200204911B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021494D0 (en) * 2000-09-01 2000-10-18 Glaxo Group Ltd Chemical comkpounds
GB0112802D0 (en) * 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112810D0 (en) * 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
AU2003258630A1 (en) 2002-08-19 2004-03-11 Glaxo Group Limited Pyrimidine derivatives as selective cox-2 inhibitors
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
GB0227443D0 (en) * 2002-11-25 2002-12-31 Glaxo Group Ltd Pyrimidine derivatives
GB0229808D0 (en) * 2002-12-20 2003-01-29 Glaxo Group Ltd Novel compositions
US7145762B2 (en) * 2003-02-11 2006-12-05 Taser International, Inc. Systems and methods for immobilizing using plural energy stores
GB0319037D0 (en) * 2003-08-13 2003-09-17 Glaxo Group Ltd 7-Azaindole Derivatives
DE102006040754B3 (de) * 2006-08-31 2008-03-27 Knorr-Bremse Systeme für Nutzfahrzeuge GmbH Scheibenbremse, insbesondere für ein Nutzfahrzeug

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58134094A (ja) 1982-02-02 1983-08-10 Mitsubishi Paper Mills Ltd 3―ホルミル―ピラゾロ〔1,5―b〕ピリダジン類
US5002941A (en) 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4925849A (en) 1987-06-15 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines
US5155114A (en) 1989-01-23 1992-10-13 Fujisawa Pharmaceutical Company, Ltd. Method of treatment using pyrazolopyridine compound
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
WO1991000092A1 (en) 1989-06-13 1991-01-10 Smithkline Beecham Corporation Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
AU622330B2 (en) 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
AU8205991A (en) 1990-06-12 1992-01-07 Smithkline Beecham Corporation Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases
GB9015764D0 (en) 1990-07-18 1990-09-05 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5300478A (en) 1993-01-28 1994-04-05 Zeneca Limited Substituted fused pyrazolo compounds
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5521213A (en) 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5552422A (en) 1995-01-11 1996-09-03 Merck Frosst Canada, Inc. Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
KR19980703559A (ko) * 1995-04-04 1998-11-05 그레이엄브레레톤 이미다조[1,2-a]피리딘 유도체
US5700816A (en) 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
CA2224563A1 (en) 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
WO1996041626A1 (en) 1995-06-12 1996-12-27 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
ES2203985T3 (es) 1997-09-05 2004-04-16 Glaxo Group Limited Derivados de 2,3-diaril-pirazolo(1,5)piridazina, su preparacion y su uso como inhibidores de la ciclooxigenasa 2(cox-2)`.
ATE261444T1 (de) * 1999-02-27 2004-03-15 Glaxo Group Ltd Pyrazolopyridine
GB9919778D0 (en) 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
HUP0203407A3 (en) 2004-12-28
US6803463B2 (en) 2004-10-12
EP1242424B1 (de) 2005-07-13
AU776777B2 (en) 2004-09-23
EP1242424A2 (de) 2002-09-25
CN1413215A (zh) 2003-04-23
NZ519691A (en) 2004-06-25
HK1047586B (en) 2005-12-16
HK1047586A1 (en) 2003-02-28
ZA200204911B (en) 2004-02-13
MXPA02006132A (es) 2002-12-05
CN1197864C (zh) 2005-04-20
AU2675101A (en) 2001-07-03
NO20023041L (no) 2002-08-16
BR0016549A (pt) 2002-09-17
NO323412B1 (no) 2007-04-30
CZ20022178A3 (cs) 2003-02-12
CA2395569A1 (en) 2001-06-28
US20030078267A1 (en) 2003-04-24
DE60021286D1 (de) 2005-08-18
ES2243343T3 (es) 2005-12-01
IL150274A0 (en) 2002-12-01
GB9930358D0 (en) 2000-02-09
NO20023041D0 (no) 2002-06-21
WO2001046194A3 (en) 2002-05-30
WO2001046194A2 (en) 2001-06-28
DE60021286T2 (de) 2005-12-29
HUP0203407A2 (hu) 2003-01-28
JP2003518121A (ja) 2003-06-03
KR20020062362A (ko) 2002-07-25
PL356141A1 (en) 2004-06-14

Similar Documents

Publication Publication Date Title
TW369526B (en) Diazabicyclic neurokinin antagonists
WO2003016282A3 (en) Substituted 1h-dihydropyrazoles, their preparation and use
UY25344A1 (es) Procedimiento para la preparacion de derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos
EA200000188A1 (ru) Производные 2,3-диарил-пиразоло[1,5-b]-пиридазинов, их получение и их применение в качестве ингибиторов циклооксигеназы-2 (цог-2)
ATE349451T1 (de) Verfahren zur herstellung von clopidogrel
YU94103A (sh) Novi derivati sulfonske kiseline
DE60021286D1 (de) Verfahren zur herstellung von pyrazolo[1,5-b]pyridazin-derivaten
CA2244139A1 (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
NZ332923A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
FI906408A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
AU8728801A (en) Method and agents on the basis of 2-mercaptopropionic acid amides for durable hair forming and a method for producing same
DK0628042T3 (da) Serotoninerge ergolinderivater
ATE268771T1 (de) Verfahren zur herstellung von pyrazolopyridinderivaten
DE3854109D1 (de) Verfahren zur herstellung von chinolincarbonsäuren.
AU5125798A (en) Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
ES554827A0 (es) Procedimiento para preparar acidos hexenoicos.
ES554830A0 (es) Procedimiento para preparar derivados de 1,3-oxatiano
HUP0104045A2 (hu) Eljárás 4-[(2',5'-diamino-6'-halogén-pirimidin-4'-il)-amino]-ciklopent-2-enilmetanol-származékok előállítására
PL367073A1 (en) Dihydroimidazo [5,1-a]-$g(b)-carboline derivatives, method for preparing same and use thereof as medicine
ATE73767T1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
HUP0201374A2 (hu) Új piperidinil-alkil-amino-piridazinon-származékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények, és eljárás a hatóanyag előállítására
HU900728D0 (en) Process for preparation of calcium antagonistics
DE3764918D1 (de) 2,6-piperazin-dion-derivate, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
TW353070B (en) Chloropyridylcarbonyl derivatives
ES2055925T3 (es) Derivados de la 9-fluor-prostaglandina, procedimiento para su obtencion y su uso farmaceutico.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties